Global X Japan Co. Ltd. Acquires 5,393 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Global X Japan Co. Ltd. raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.7% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 51,682 shares of the medical equipment provider’s stock after acquiring an additional 5,393 shares during the quarter. Intuitive Surgical comprises 2.9% of Global X Japan Co. Ltd.’s portfolio, making the stock its 13th largest position. Global X Japan Co. Ltd.’s holdings in Intuitive Surgical were worth $25,597,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Premier Path Wealth Partners LLC boosted its position in shares of Intuitive Surgical by 1.4% in the 1st quarter. Premier Path Wealth Partners LLC now owns 2,824 shares of the medical equipment provider’s stock worth $1,399,000 after purchasing an additional 39 shares during the last quarter. Johnson Investment Counsel Inc. boosted its holdings in Intuitive Surgical by 6.0% during the first quarter. Johnson Investment Counsel Inc. now owns 28,144 shares of the medical equipment provider’s stock worth $13,939,000 after buying an additional 1,599 shares during the last quarter. Beacon Capital Management LLC boosted its holdings in Intuitive Surgical by 12.8% during the first quarter. Beacon Capital Management LLC now owns 202 shares of the medical equipment provider’s stock worth $100,000 after buying an additional 23 shares during the last quarter. State of Alaska Department of Revenue boosted its holdings in Intuitive Surgical by 2.9% during the first quarter. State of Alaska Department of Revenue now owns 41,789 shares of the medical equipment provider’s stock worth $20,696,000 after buying an additional 1,170 shares during the last quarter. Finally, LifeWealth Investments LLC bought a new position in Intuitive Surgical during the first quarter worth about $206,000. 83.64% of the stock is owned by institutional investors.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the sale, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at $2,695,113.84. The trade was a 3.47% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Mark Brosius sold 216 shares of the company’s stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president now owns 907 shares in the company, valued at $510,740.77. The trade was a 19.23% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock valued at $2,611,577 over the last 90 days. 0.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Thursday, June 5th. Citigroup reissued a “buy” rating and set a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Evercore ISI reduced their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a research report on Wednesday, April 23rd. Piper Sandler reduced their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 23rd. Finally, Deutsche Bank Aktiengesellschaft lowered Intuitive Surgical from a “hold” rating to a “sell” rating and reduced their target price for the stock from $515.00 to $440.00 in a report on Monday, June 9th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $588.95.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $509.49 on Thursday. The firm has a market cap of $182.61 billion, a price-to-earnings ratio of 74.71, a price-to-earnings-growth ratio of 5.43 and a beta of 1.67. The stock’s 50-day moving average is $527.31 and its 200-day moving average is $537.92. Intuitive Surgical, Inc. has a one year low of $413.82 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter in the previous year, the business posted $1.50 EPS. On average, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.